Literature DB >> 20185194

Non-invasive assessment of hepatic steatosis: prospective comparison of the accuracy of imaging examinations.

Seung Soo Lee1, Seong Ho Park, Hye Jin Kim, So Yeon Kim, Min-Yeong Kim, Dae Yoon Kim, Dong Jin Suh, Kang Mo Kim, Mi Hyun Bae, Joo Yeon Lee, Sung-Gyu Lee, Eun Sil Yu.   

Abstract

BACKGROUND & AIMS: Despite increasing use of various imaging examinations for non-invasive assessment of hepatic steatosis (HS), their relative accuracy is unknown. The objective of this study is to prospectively compare the accuracy of computed tomography (CT), dual gradient echo magnetic resonance imaging (DGE-MRI), proton magnetic resonance spectroscopy ((1)H-MRS), and ultrasonography (US) for the diagnosis and quantitative estimation of HS.
METHODS: A total of 161 consecutive potential living liver donors underwent US (performed by two independent radiologists, US1 and US2), CT, DGE-MRI, (1)H-MRS, and liver biopsy on the same day. Using the histologic degree of HS as the reference standard, we compared the diagnostic performance of US1, US2, CT, DGE-MRI, and (1)H-MRS for diagnosing HS >or= 5% and HS >or= 30% and compared the accuracy of CT, DGE-MRI, and (1)H-MRS in the quantitative estimation of HS.
RESULTS: DGE-MRI and (1)H-MRS significantly outperformed CT and US for the diagnosis of HS5%. DGE-MRI showed a tendency of higher accuracy than the other examinations for diagnosing HS >or= 30%. The cross-validated sensitivity and specificity of DGE-MRI at the optimal cut-off were 76.7% and 87.1%, respectively, for diagnosing HS >or= 5% and 90.9% and 94%, respectively, for diagnosing HS >or= 30%. The cross-validated Bland-Altman 95% limits of agreement between the estimated degree of HS on imaging examinations and the histologic degree of HS, were the narrowest with DGE-MRI, yielding -12.7% to 12.7%.
CONCLUSIONS: Among CT, DGE-MRI, (1)H-MRS, and US, DGE-MRI is the most accurate method for the diagnosis and quantitative estimation of HS. Therefore, DGE-MRI may be the preferred imaging examination for the non-invasive assessment of HS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20185194     DOI: 10.1016/j.jhep.2010.01.008

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  100 in total

1.  CT indices for the diagnosis of hepatic steatosis using non-enhanced CT images: development and validation of diagnostic cut-off values in a large cohort with pathological reference standard.

Authors:  Jieun Byun; Seung Soo Lee; Yu Sub Sung; Youngbin Shin; Jessica Yun; Ho Sung Kim; Eun Sil Yu; Sung-Gyu Lee; Moon-Gyu Lee
Journal:  Eur Radiol       Date:  2018-12-19       Impact factor: 5.315

2.  Assessment of relevant hepatic steatosis in obese adolescents by rapid fat-selective GRE imaging with spatial-spectral excitation: a quantitative comparison with spectroscopic findings.

Authors:  Fabian Springer; Stefan Ehehalt; Julia Sommer; Verena Ballweg; Jürgen Machann; Gerhard Binder; Claus D Claussen; Fritz Schick
Journal:  Eur Radiol       Date:  2010-10-03       Impact factor: 5.315

Review 3.  Efficacy and Safety of Intragastric Balloon (IGB) in Non-alcoholic Fatty Liver Disease (NAFLD): a Comprehensive Review and Meta-analysis.

Authors:  Saurabh Chandan; Babu P Mohan; Shahab R Khan; Antonio Facciorusso; Daryl Ramai; Lena L Kassab; Neil Bhogal; Ravishankar Asokkumar; Gortrand Lopez-Nava; Stephanie McDonough; Douglas G Adler
Journal:  Obes Surg       Date:  2021-01-06       Impact factor: 4.129

4.  Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.

Authors:  Jie Deng; Mark H Fishbein; Cynthia K Rigsby; Gang Zhang; Samantha E Schoeneman; James S Donaldson
Journal:  Pediatr Radiol       Date:  2014-05-20

5.  Nonalcoholic fatty liver disease: MR imaging of liver proton density fat fraction to assess hepatic steatosis.

Authors:  An Tang; Justin Tan; Mark Sun; Gavin Hamilton; Mark Bydder; Tanya Wolfson; Anthony C Gamst; Michael Middleton; Elizabeth M Brunt; Rohit Loomba; Joel E Lavine; Jeffrey B Schwimmer; Claude B Sirlin
Journal:  Radiology       Date:  2013-02-04       Impact factor: 11.105

Review 6.  Liver fat imaging-a clinical overview of ultrasound, CT, and MR imaging.

Authors:  Yingzhen N Zhang; Kathryn J Fowler; Gavin Hamilton; Jennifer Y Cui; Ethan Z Sy; Michelle Balanay; Jonathan C Hooker; Nikolaus Szeverenyi; Claude B Sirlin
Journal:  Br J Radiol       Date:  2018-06-06       Impact factor: 3.039

Review 7.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

Authors:  Mustafa Koplay; Mesut Sivri; Hasan Erdogan; Alaaddin Nayman
Journal:  World J Hepatol       Date:  2015-04-18

Review 8.  Evidence and recommendations for imaging liver fat in children, based on systematic review.

Authors:  Hannah I Awai; Kimberly P Newton; Claude B Sirlin; Cynthia Behling; Jeffrey B Schwimmer
Journal:  Clin Gastroenterol Hepatol       Date:  2013-09-30       Impact factor: 11.382

9.  Quantitative analysis of hepatic fat fraction by single-breath-holding MR spectroscopy with T₂ correction: phantom and clinical study with histologic assessment.

Authors:  Norio Hayashi; Tosiaki Miyati; Takashi Minami; Yumie Takeshita; Yasuji Ryu; Tsuyoshi Matsuda; Naoki Ohno; Takashi Hamaguchi; Kenichiro Kato; Toshinari Takamura; Osamu Matsui
Journal:  Radiol Phys Technol       Date:  2012-12-07

Review 10.  Radiologic evaluation of nonalcoholic fatty liver disease.

Authors:  Seung Soo Lee; Seong Ho Park
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.